𝔖 Bobbio Scriptorium
✦   LIBER   ✦

B19 parvovirus infection in children with malignant solid tumors receiving chemotherapy

✍ Scribed by Rao, Sreedhar P. ;Miller, Scott T. ;Cohen, Bernard J.

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
227 KB
Volume
22
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Two children with rhabdomyosarcoma developed severe anemia following chemotherapy; anemia was more severe compared to that observed following earlier chemotherapy cycles. While one patient had a brisk reticulocytosis, the other had no demonstrable reticulocytes. Both patients had evidence of acute B19 parvovirus infection and subsequently developed appropriate antibody response. A diagnosis of B19 parvovirus infection should be considered in any patient who develops persistent or severe anemia while on chemotherapy. © 1994 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Infection with hepatitis A, B, Delta, An
Infection with hepatitis A, B, Delta, And human immunodeficiency viruses in children receiving cycled cancer chemotherapy
✍ Dr. Archana Kumar; P. K. Misra; G. S. Rana; Raj Mehrotra 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB

## Abstract Serological markers of hepatitis A, B, and Delta and human immunodeficiency viruses were studied in 25 children receiving cancer chemo‐therapy. Eighty‐eight percent had pre‐existing HAV immunity which was unaltered by chemo‐therapy. HDV infection was observed in 8% while HIV was conspic

Ototoxicity in children with malignant b
Ototoxicity in children with malignant brain tumors treated with the “8 in 1” chemotherapy protocol
✍ Ilveskoski, Ismo; Saarinen, Ulla M.; Wiklund, Tom; Perkkiö, Mikko; Salmi, Toivo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views

Background. Adjuvant chemotherapy has improved the outcome of childhood malignant brain tumors in large randomized trials. With increasing survival rates, treatment toxicity has become a matter of concern. Radiation therapy and cisplatinum are known to be ototoxic. Methods. We evaluated the inciden

Phase I trial of subcutaneous interleuki
Phase I trial of subcutaneous interleukin-1α in children with malignant solid tumors
✍ Furman, Wayne L.; Luo, Xiaolong; Fairclough, Diane; Garrison, Leslie; Marina, Ne 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Interleukin-1 alpha (IL-1 alpha) is myeloprotective in a variety of animal models of cancer chemotherapy and is similarly beneficial in adults treated with carboplatin, 5-fluorouracil, and after autologous bone marrow transplantation. There are no trials of this agent in children. Our purpose was to

Recombinant human erythropoietin for the
Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors
✍ León, Pedro; Jiménez, Miguel; Barona, Pascual; Sierrasesúmaga, Luis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Background. Cancer is often associated with chronic anemia which frequently requires blood transfusions. This study was performed to assess the efficacy and safety of r-HuEPO therapy in children with cancer. Patients and methods. Twenty-five patients under 18 years of age with solid malignant